Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE
|
|
|
- Shannon Terry
- 10 years ago
- Views:
Transcription
1 Rome, Italy December 4-7, 2012 Rome Cavalieri
2 Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP) 08.30/10.45 Session I: Clinical Electrocardiography: Managing complex and challenging cases Fundamentals of surface and endocavitary ECG interpretation 10.45/11.00 Coffee Break 11.00/12.15 Session II: Treating Arrhythmias and Heart Failure: A tailored approach for the patient Sudden death prevention 12.15/13.15 Lunch 13.15/14.15 Session II: Treating Arrhythmias and Heart Failure: A tailored approach for the patient Cardiac resynchronization therapy 14.15/14.30 Coffee Break 14.30/16.15 Session III: Novel Concepts in the Treatment of Atrial Fibrillation Device therapy 16.15/16.30 Coffee Break 16.30/18.00 Session III: Novel Concepts in the Treatment of Atrial Fibrillation Ablation therapy Where do we stand Reception and Group Dinner 14
3 Tuesday, December 4 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP) 08.00/10.30 Session IV: Managing Complex Arrhythmic and Device Patients 15
4 Tuesday, December 4 Room A Room B Room C Room D 08.30/10.30 PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS Session I: Health care funding 11.00/13.00 PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS CARDIAC MAGNETIC RESONANCE IN ARRHYTHMIC DISEASES VAGAL STIMULATION IN ARRHYTHMIAS AND HEART FAILURE MINICOURSE PHARMACOLOGICAL TREATMENT OF CARDIAC ARRHYTHMIAS: OLD AND NEW DRUGS AVAILABLE Session II: The role of the medical community 13.15/14.45 PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS Joint Session with WSA LUNCHEON PANEL Few women in electrophysiology Joint Session with World Society of Arrhythmias (WSA) 15.00/ /19.30 Session III: State of the art PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS Session IV: Reducing costs by appropriate device/ selection technique and patient follow-up OPENING CEREMONY MAGISTRAL LECTURE DUTY-CYCLED PHASED RF: THE EVOLUTION OF RF ABLATION 17.00/17.30 BREAK PM/ICD PATIENTS WITH BORDERLINE HAEMODYNAMIC CONDITIONS: A NEW ROLE FOR PREVENTIVE CRT? HOME MONITORING: FROM CLINICAL VALIDATION TO A WIDER ADOPTION 16
5 Room E Room F Room G Room H INTERNATIONAL ON ANTICOAGULATION Session I: Debated topics in anticoagulation MINICOURSE CLINICAL MANAGEMENT OF VENTRICULAR tachyarrhythmias: FROM DRUGS TO SURGERY DEBATABLE SENTENCES IN ATRIAL FIBRILLATION TREATMENT INTERNATIONAL ON ANTICOAGULATION Session II: The new era of oral anticoagulation MINICOURSE ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION. CLINICAL QUESTIONS IN THE DAILY PRACTICE Session I CARDIAC ARRHYTHMIAS LONG TERM CLINICAL OUTCOME: NATURAL HISTORY 25 YEARS LATER reliability of technology in device use 17.00/17.30 BREAK 15 YEARS OF INNOVATION IN AF AND HF TREATMENT: WHAT IS THE NEXT BIG THING? MINICOURSE ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION. CLINICAL QUESTIONS IN THE DAILY PRACTICE Session II 17
6 Wednesday, December 5 Room A Room B Room C Room D 08.30/10.30 PHYSIOLOGICAL PACING. SCIENTIFIC EVIDENCE CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION Session I: Redefining pulmonary vein isolation STROKE PREVENTION BY NEW IMPLANTABLE TECHNOLOGY INTRODUZIONE AL CONTROLLO REMOTO DEI DISPOSITIVI IMPIANTABILI 11.00/13.00 PATIENT ACCESS TO DEVICE THERAPY: HOW CAN NEW TECHNOLOGIES HELP TO PROVIDE ALL PATIENTS WITH THE TAILORED THERAPY? CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION Session II: The new standard of care for PVI? PATIENTS MANAGEMENT IN THE REMOTE MONITORING ERA TECNOLOGIE DISPONIBILI 13.15/14.45 CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION Session III: Clinical case presentations LUNCHEON PANEL MANAGEMENT OF ACUTE- DECOMPENSATED HEART FAILURE WITH FLUID OVERLOAD SYNDROME: ULTRAFILTRATION? 15.00/ /19.00 MANAGING IMPLANTABLE DEVICES AND LEAD FAILURES IDENTIFIED BY REMOTE CONTROL STANDARD OF CARE IN CRT: HOW TO REDUCE ADVERSE EVENT AND IMPROVE PATIENT OUTCOME / BREAK ENDOCAVITARY ELECTRICAL CARDIOVERSION MODELLI ORGANIZZATIVI /
7 Room E Room F Room G Room H GLOBAL ARRHYTHMIA Joint Session WSA-CSPE Session I: Current status and Debatable Topics on Cardiac Pacing DEBATABLE SENTENCES IN VENTRICULAR TACHYCARDIA TREATMENT NEWS ON ATRIAL FIBRILLATION THERAPY SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT Session I: Atrial fibrillation GLOBAL ARRHYTHMIA Joint Session WSA-CSPE Session II: Remote Monitoring and Case study MODERN IMPLANTABLE DIAGNOSTIC TOOLS REMOTELY CONTROLLED HAEMODYNAMIC REGULATION OF CARDIAC PACING THROUGH THE TVI SENSOR: APPLICATIONS IN CLINICAL PRACTICE SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT Session II: Ventricular arrhythmias LUNCHEON PANEL STEM CELLS AND CARDIAC ARRHYTHMIAS ENDOCAVITARY MAPPING AND ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION HEART FAILURE AND CARDIAC ARRHYTHMIAS: CLINICAL ISSUES / BREAK BREAKTHROUGH INNOVATION IN HEALTH CARE TRANSCATHETER RADIOFREQUENCY ABLATION IN THE RENAL ARTERIES: A GLIMPSE INTO THE FUTURE? 19
8 Thursday, December 6 Room A Room B Room C Room D 08.30/10.30 PERMANENT CARDIAC PACING IN NEUROMEDIATED SYNCOPE CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION Session IV: First option therapy? EURO-JAPAN ARRHYTHMIA (EJAF) Session I: Debatable sentences in the treatment of syncope IL MONITORAGGIO REMOTO NELLA DIAGNOSI E TRATTAMENTO DELLE TACHIARITMIE ATRIALI / BREAK AND POSTER VISIT 11.00/13.00 MRI COMPATIBLE IMPLANTABLE DEVICES Cryoablation in different clinical settings EURO-JAPAN ARRHYTHMIA (EJAF) Session II: Hot topics in genetic arrhythmic syndromes IL MONITORAGGIO REMOTO NEI PAZIENTI CON TACHIARITMIE VENTRICOLARI 13.15/ / /19.00 CRT AND BEYOND IN HEART FAILURE TREATMENT LUNCHEON PANEL ROLE OF CARDIAC CONTRACTILITY MODULATION IN THE TREATMENT AND PREVENTION OF HF CLINICAL UPDATE ON AF AND HF PATIENT MANAGEMENT ABLATION AND SCD Joint Session with Asia Pacific Heart Rhythm Society (APHRS) / BREAK AND POSTER VISIT IL MONITORAGGIO REMOTO nella gestione del paziente con scompenso cardiaco /
9 Room E Room F Room G Room H ADVANCED TECHNIQUES AND TECHNOLOGIES IN THE EP LABORATORY: WHEN AND HOW? HEART FAILURE: EXPLORE LINKED TOPICS EXPLORING THE STATE OF THE ART IN CARDIAC RESYNCHRONIZATION THERAPY SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT Session III: Cardiac resynchronization therapy / BREAK AND POSTER VISIT TOWARDS CRT RESPONSE MAXIMIZATION Case based session PHARMACOLOGICAL TREATMENT OF CARDIAC ARRHYTHMIAS EPIDEMIOLOGY AND BURDEN OF ATRIAL FIBRILLATION: NEW ISSUES AND CHALLENGES SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT Session IV: Early and late arrhythmic comorbidity after heart surgery: how to avoid, how to treat? LUNCHEON PANEL HAEMODYNAMIC BASED CRT OPTIMIZATION update in crt VENOUS THROMBOSIS IN DEVICE PATIENTS ANTITACHY ATRIAL PACING TO TREAT PAROXYSMAL ATRIAL TACHYARRHYTHMIAS / BREAK AND POSTER VISIT ALTERNATIVE PACING SITES 21
10 Friday, December 7 Room A Room B Room C Room D 08.30/10.30 MONITORING HEART FAILURE BY REMOTE CONTROL OF IMPLANTED DEVICES MANAGEMENT OF ATRIAL FIBRILLATION: ABLATION, MONITORING AND WHAT ELSE? EURO-JAPAN ARRHYTHMIA (EJAF) Session III: Clinical management of atrial fibrillation from drugs to surgical ablation IL MONITORAGGIO REMOTO nella gestione delle malfunzioni 11.00/13.00 NEW MODELS TO MANAGE IN OUT OF HOSPITAL PATIENTS WITH IMPLANTED DEVICES EMERGING ISSUES IN DEVICE PATIENTS: SOLUTIONS & PERSPECTIVES EURO-JAPAN ARRHYTHMIA (EJAF) Session IV: Clinical impact of new technologies IL MONITORAGGIO REMOTO nella gestione del loop recorder impiantabile 13.00/14.30 aspetti legali ed economici nel monitoraggio remoto /
11 Room E Room F Room G Room H REUSE OF IMPLANTABLE DEVICES CATHETER ABLATION IN PEDIATRIC PATIENTS: selecting appropriate timing and technique RIGHT VENTRICULAR PERMANENT PACING THE EP LAB OF THE FUTURE MINICOURSE PERMANENT ANTICOAGULATION IN ARRHYTHMIC PATIENTS ICD PATIENTS OUTCOME STROKE PREVENTION BY AF PREVENTION AND TREATMENT ALTERNATIVES TO TRANSVENOUS ICD session pic: PROGRESS IN INTERVENTIONAL CARDIOLOGY. II EDITION /
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
Patient Information Sheet Electrophysiological study
Patient Information Sheet Electrophysiological study Your doctor has recommended performing an electrophysiological study (also called EPS). EPS is a diagnostic procedure designed to test and evaluate
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
Ngaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
How should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
Massachusetts General Hospital Fellowship Training Program in Clinical Cardiac Electrophysiology
Massachusetts General Hospital Fellowship Training Program in Clinical Cardiac Electrophysiology Program Director: Jeremy N. Ruskin, M.D. Program Administrators: Elizabeth Kelly, RN and Lisa DeFabritiis
Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen
Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen PhD course: Cardiac arrhythmias - Aim and content: Cardiac arrhythmia represents a wide spectrum of abnormalities
Recurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
CURRICULUM VITAE Prof. ANTONIO CURNIS
CURRICULUM VITAE Prof. ANTONIO CURNIS I. Personal Informations - Born in February 11 th 1958 in Bergamo (Italy). - Graduated by University of Brescia 23.10.88 - Division of Cardiology of Civil Hospital
Catheter Ablation. A Guided Approach for Treating Atrial Arrhythmias
Catheter Ablation A Guided Approach for Treating Atrial Arrhythmias A P A T I E N T H A N D B O O K This brochure will provide an overview of atrial arrhythmias (heart rhythm problems affecting the upper
21st Annual OSF Cardiovascular Symposium
21st Annual OSF Cardiovascular Symposium new waves in cardiac electrophysiology saturday 18 october 2014 7:00 a.m. 4:00 p.m. embassy suites conference center east peoria, illinois OBJECTIVES Overall Program:
Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy
Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.
Management of Symptomatic Atrial Fibrillation
Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015
Cardiology ARCP Decision Aid August 2014
Cardiology ARCP Decision Aid August 2014 The table that follows includes a column for each training year which documents the targets that have to be achieved for a satisfactory ARCP outcome at the end
EDUCATION Northern Illinois University BSN 1993 Nursing Science Rush University Medical Center MSN 2005 Nursing Science
MARIPAT KING RN MSN ACNP Curriculum Vitae Department of Biobehavioral Health Science University of Illinois College of Nursing 845 South Damen Ave, Chicago IL 60612 312-413-7340 (TEL) 312-996-4979 (FAX)
What Are Arrhythmias?
What Are Arrhythmias? Many people have questions about what the word arrhythmia means, and arrhythmias can be a difficult subject to understand. The text below should give you a better understanding of
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short
Establishing a Remote Monitoring Program. Martha Ferrara, FNP
Establishing a Remote Monitoring Program Martha Ferrara, FNP Establishing a Remote Monitoring Program What is Remote Monitoring? Martha Ferrara, FNP, CCDS November 2012 CIED Timeline: Cardiovascular Implantable
Electrophysiology Heart Study - EPS -
Electrophysiology Heart Study - EPS - What is an EPS? EPS is short for ElectroPhysiology heart Study. This procedure looks at the electrical system of your heart. An EPS will show if you have a heart rhythm
UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:
UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: Electrophysiology Implant Code Classification Table The
Advances in the Treatment of Atrial Fibrillation At VCU Medical Center
Contact Us For additional information or to schedule an appointment with one of our specialists, please call: Ken Ellenbogen, M.D. Cardiology/Electrophysiology 804-828-7565 or 804-628-0147 You can also
CARDIOLOGY Delineation of Privileges
CARDIOLOGY Delineation of Privileges APPLICANT: INITIAL APPOINTMENT REQUIREMENTS: BASIC EDUCATION: M.D. or D.O. from an accredited school of medicine or osteopathy. Successful completion of an ACGME or
Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE
CARDIAC NURSING. Graduate Diploma in Nursing Science. Overview. Entry Requirements. Fees. Contact. Teaching Methods.
Graduate Diploma in Nursing Science CARDIAC NURSING Overview The Graduate Diploma in Nursing Science (Cardiac Nursing) is designed to develop advanced theoretical knowledge and specialist skills essential
Telecardiology Technical Innovations and Challegenes in Clinical Practice
Telecardiology Technical Innovations and Challegenes in Clinical Practice Axel Müller Clinic of Internal Medicine I (Head of Department: Prof. Dr. med. J. Schweizer) Klinikum Chemnitz ggmbh June 24, 2015
Atrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges
NAME Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges GENERAL CARDIOLOGY Required Qualifications for General Cardiology Education/Training/Experience Must have
Atrial Fibrillation (AF) Explained
James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common
Medical Tourism - The Role of Intervals inCardiovascular Cancer
Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)
2013 Medicare Physician Coding and Reimbursement Changes
2013 Medicare Physician Coding and Reimbursement Changes Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent of Medtronic s Economic Strategies
Tachyarrhythmias (fast heart rhythms)
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
Surgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
Dr. Sven Bode 24. Treffpunkt Medizintechnik 1. Juli 2010. Telemetrische Herzüberwachung Eine Dekade BIOTRONIK Home Monitoring
Dr. Sven Bode 24. Treffpunkt Medizintechnik 1. Juli 2010 Telemetrische Herzüberwachung Eine Dekade BIOTRONIK Home Monitoring RF GPRS GPRS https 0 Agenda Introduction to active implants and Home Monitoring
Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN
Basics of Pacing Ruth Hickling, RN-BSN Tasha Conley, RN-BSN The Cardiac Conduction System Cardiac Conduction System Review Normal Conduction Conduction QRS QRS Complex Complex RR PP ST ST segment segment
SUTTER MEDICAL CENTER, SACRAMENTO Department of Cardiovascular Disease Cardiology - Delineation of Privileges
INITIAL: [ ] RENEWED: [ ] DATE: ADDITIONAL: [ ] Privileges are granted for Sutter General Hospital, Sutter Memorial Hospital, Sutter Center for Psychiatry, Sutter Oaks Midtown and the Capitol Pavilion
Reimbursement Information For Electrophysiology and Arrhythmia Service Procedures 1
GE Healthcare Information For Electrophysiology and Arrhythmia Procedures 1 2011 Update www.gehealthcare.com/reimbursement This overview addresses coding, coverage, and payment for electrophysiology procedures
Presenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
Cardiac Rhythm Device Summit:
Division of Cardiovascular Diseases Cardiac Rhythm Device Summit: Implantation, Management, and Follow Up June 17-19, 2016 Swissotel Chicago Course Directors: LEARN. ADVANCE. CONNECT. celinks.mayo.edu/cardiacdevice2016
Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure
Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure Gaetano M. De Ferrari, MD Dept. of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy for the CardioFit
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter
22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release
Treatments to Restore Normal Rhythm
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
What Can I Do about Atrial Fibrillation (AF)?
Additional Device Information 9529 Reveal XT Insertable Cardiac Monitor The Reveal XT Insertable Cardiac Monitor is an implantable patientactivated and automatically activated monitoring system that records
ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements
Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary
Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist
Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an
Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN
ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN Dear Colleague: Cardiovascular medicine has marked an important milestone in the battle against heart disease. The latest available data indicates
Innovations and New Treatment Strategies in Heart Failure
Innovations and New Treatment Strategies in Heart Failure 8th International Symposium, September 18th- 19th, 2015 Portorož, Slovenia Friday September 18th Morning Sessions 9.00-9.15 Opening Session 1 Heart
Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media
News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban
Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
Automatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
LEADING-EDGE Cardiovascular Care
LEADING-Edge Cardiovascular Care Coral Gables Hospital North Shore Medical Center Hialeah Hospital Delray Medical Center Good Samaritan Medical Center Palm Beach Gardens Medical Center St. Mary s Medical
Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS
Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES Sec. 138.1 Principle. 138.2. Definitions. GENERAL PROVISIONS PROGRAM, SERVICE, PERSONNEL AND AGREEMENT REQUIREMENTS
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
How do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
FY2015 Proposed Hospital Inpatient Rule Summary
FY2015 Proposed Hospital Inpatient Rule Summary Cardiac Rhythm Management (CRM) Electrophysiology (EP) Interventional Cardiology (IC) Peripheral Intervention (PI) On April 30, 2014, the Centers for Medicare
CARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM
Sesto San Giovanni PRELIMINARY PROGRAM PRESIDENTS Sesto San Giovanni G. J. Klein University Hospital Card Inv Unit London Ontario Canada A. S. Montenero IRCCS Multimedica Cardiology Dpt. Sesto San Giovanni
Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs
Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population Carel Jan Willem Borleffs The studies described in this thesis were performed at the Department
GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)
AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support) The term cardiac arrhythmia
CCAD Training Manual. Cardiac Rhythm Management (CRM)
CCAD Training Manual Cardiac Rhythm Management (CRM) Version 1.0 A D Cunningham 19/3/2008 Introduction This manual is intended to assist users of the Notes Client version of the CCAD Cardiac Rhythm Management
CATHETER ABLATION for ATRIAL FIBRILLATION
CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street
Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation
Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation Authors: Bijesh Maroo MD David Elizardi MD, FACC Hector Ventura MD, FACC This document was created with
CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL
Outline of Cardiology Training Chapter 6 Article 1 CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL 1.1. The central monitoring authority for the specialty will be the European Board for the Specialty
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
Atrial Fibrillation (AF) March, 2013
Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one
Cardiology. Physician and Paediatrician Training Program Cardiology Advanced Training Curriculum
Cardiology Physician and Paediatrician Training Program Cardiology Advanced Training Curriculum Advanced Training Curriculum To be used in conjunction with: Basic Training Curricula Adult Internal Medicine
Update on Indications, Techniques and Controversies for Lead Extraction
Update on Indications, Techniques and Controversies for Lead Extraction W Boston 100 Stuart Street, Boston, MA Course Directors Avi Fischer, MD Laurence M. Epstein, MD Brigham and Women s Hospital Sponsored
Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
Atrial fibrillation (AF) care pathways. for the primary care physicians
Atrial fibrillation (AF) care pathways for the primary care physicians by University of Minnesota Physicians Heart, October, 2011 Evaluation by the primary care physician: 1. Comprehensive history and
CARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE
CARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE Maarten L Simoons Thoraxcenter Erasmus MC Rotterdam President ESC 2000-2002 Cardiology, the next 10 years (?) Break through of genetics cardiomyopathy, ion channel
Atrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians May 19, 2015 Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
Diagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013
1. INTRODUCTION STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013 This document replaces the previous Heart Rhythm UK documents Clinical Guidance by Consensus
THE ACADEMY OF MEDICINE OF MALAYSIA January 2005 CREDENTIALING REQUIREMENTS FOR THE SPECIALITY OF CARDIOLOGY
THE ACADEMY OF MEDICINE OF MALAYSIA January 2005 CREDENTIALING REQUIREMENTS FOR THE SPECIALITY OF CARDIOLOGY 1 Contents 1. 2. 3. Introduction, Aims, Objectives and Terms of Reference Cardiology Advisory
